Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
loss. The Researcher/ Scientist IV will lead and develop projects in an ongoing research program that focuses on the identification and development of targeted proteomic therapies for hearing loss
-
cellular uptake and intracellular trafficking of targeted cancer nanomedicines using appropriate techniques such as Western blotting, qPCR, IHC, flow cytometry, and proteomics. Evaluates the pharmacokinetics
-
technologies for transcriptomic, proteomic, and metabolomic studies. Complete the assigned work in time. Complete complex research projects at different stages (advanced through nearly completed). Formulate
-
to the organism, including iPSC-derived cardiomyocytes, organoids, and animal models. This includes molecular biology (RNAseq and proteomics), biochemistry, measuring cardiac function (echocardiography), pressure
-
RNA-sequencing, scRNA-sequencing, bioinformatics, qRT-PCR, Immunoblotting, proteomics and metabolomics, and Immunocytofluorescence, primary cell isolation and culture, seahorse analysis, and
-
software and workflows for genomic and proteomic data analysis. The selected candidate will lead development efforts for both high-performance command-line analysis software and cloud-based web services
-
analytical and statistical methods. Contribute to ongoing studies in cardiovascular systems biology, including exposure to proteomics, transcriptomics, and integrative data analysis approaches. Interpret
-
enthusiasm for working with a mid-sized academic team to develop optimized software and workflows for genomic and proteomic data analysis. The selected candidate will lead development efforts for both high